dapagliflozin
astrazeneca
['dapagliflozin', 'cardio']
 final results of deliver dapagliflozin reduced the combined pe, mainly driven by reduced hf rehospitalization in patients with hfpef. however, no significant reduction in cardiovascular mortality. #esccongress 
Heart Center Bonn / Cardiologist / Clinician Scientist